View More Recent Stories

Dec 17, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Dec 17, 2024 06:34AM Oppenheimer Reiterates Outperform Rating on Viridian Therapeutic (VRDN)

Dec 16, 2024 07:05AM Viridian Therapeutics (VRDN) Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease

Nov 25, 2024 05:32AM TD Cowen Starts Viridian Therapeutic (VRDN) at Buy

Nov 14, 2024 06:57AM Viridian Therapeutic (VRDN) PT Raised to $34 at H.C. Wainwright

Nov 12, 2024 10:51AM Viridian Therapeutic (VRDN) PT Raised to $41 at Stifel

Nov 12, 2024 07:24AM Viridian Therapeutics, Inc. (VRDN) Misses Q3 EPS by 9c

Oct 28, 2024 07:19AM Needham Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Oct 28, 2024 06:04AM Goldman Sachs Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Sep 13, 2024 06:33AM Viridian Therapeutic (VRDN) PT Raised to $44 at RBC Capital

Sep 12, 2024 06:12AM Viridian Therapeutics (VRDN) Prices Upsized 10.67M Share Offering at $18.75/sh

Sep 12, 2024 05:07AM Viridian Therapeutic (VRDN) PT Raised to $31 at Goldman Sachs

Sep 11, 2024 07:12AM Viridian Therapeutic (VRDN) PT Raised to $38 at Needham

Sep 11, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Sep 11, 2024 06:25AM Viridian Therapeutic (VRDN) PT Raised to $22 at B.Riley

Sep 10, 2024 04:33PM After-hours movers: GameStop, Dave & Buster's, Viridian Therapeutics

Sep 10, 2024 04:01PM Viridian Therapeutics (VRDN) Announces Proposed $150M Share and Warrant Offering

Sep 10, 2024 01:08PM Viridian Therapeutic (VRDN) PT Raised to $40 at Stifel

Sep 10, 2024 11:41AM Viridian Therapeutic (VRDN) PT Raised to $56 at BTIG

Sep 10, 2024 07:02AM Viridian Therapeutics (VRDN) Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease

Aug 30, 2024 07:35AM Needham Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Aug 14, 2024 03:58PM Goldman Sachs Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Jul 25, 2024 02:29PM Viridian Therapeutics (VRDN) September 15 puts active as share price trades $16.53

Jul 16, 2024 10:52AM H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Jul 15, 2024 01:23PM BTIG Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Jun 11, 2024 12:52PM Goldman Sachs Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Jun 11, 2024 12:47PM RBC Capital Reiterates Outperform Rating on Viridian Therapeutic (VRDN)

Jun 11, 2024 12:32PM BTIG Reiterates Buy Rating on Viridian Therapeutic (VRDN)

Jun 11, 2024 05:02AM Wolfe Research Starts Viridian Therapeutic (VRDN) at Outperform

View More Recent Stories